D. Dalela

581 total citations
44 papers, 382 citations indexed

About

D. Dalela is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, D. Dalela has authored 44 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Urology and 7 papers in Molecular Biology. Recurrent topics in D. Dalela's work include Urological Disorders and Treatments (12 papers), Urinary Bladder and Prostate Research (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). D. Dalela is often cited by papers focused on Urological Disorders and Treatments (12 papers), Urinary Bladder and Prostate Research (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). D. Dalela collaborates with scholars based in India, United States and Germany. D. Dalela's co-authors include Apul Goel, Satya Narain Shankhwar, Pratipal Singh, Anupam Srivastava, Madan Lal Brahma Bhatt, Srikanta Kumar Rath, Krishna M. Singh, Madhu Mati Goel, Pankaj Kumar Singh and Rajiv Agarwal and has published in prestigious journals such as Blood, Cancer Research and The Journal of Urology.

In The Last Decade

D. Dalela

41 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Dalela India 11 162 118 92 70 48 44 382
Fernando Gabilondo Mexico 13 169 1.0× 76 0.6× 118 1.3× 212 3.0× 82 1.7× 28 514
Kyu-Rae Kim South Korea 11 117 0.7× 76 0.6× 71 0.8× 43 0.6× 78 1.6× 22 415
J Dvořáček Czechia 13 350 2.2× 84 0.7× 148 1.6× 130 1.9× 60 1.3× 56 609
Calogero Virgone Italy 13 391 2.4× 50 0.4× 68 0.7× 62 0.9× 82 1.7× 50 531
Mitsuhiro Tambo Japan 12 131 0.8× 62 0.5× 194 2.1× 50 0.7× 92 1.9× 45 409
B Court France 12 305 1.9× 96 0.8× 179 1.9× 115 1.6× 35 0.7× 29 453
D. Rosell Spain 12 174 1.1× 87 0.7× 225 2.4× 34 0.5× 31 0.6× 50 401
E Kairi-Vassilatou Greece 13 189 1.2× 24 0.2× 96 1.0× 20 0.3× 87 1.8× 35 384
Giuseppe Di Fino Italy 13 148 0.9× 36 0.3× 159 1.7× 80 1.1× 42 0.9× 26 374
G. Hofmockel Germany 11 198 1.2× 162 1.4× 331 3.6× 57 0.8× 167 3.5× 44 552

Countries citing papers authored by D. Dalela

Since Specialization
Citations

This map shows the geographic impact of D. Dalela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dalela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dalela more than expected).

Fields of papers citing papers by D. Dalela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Dalela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dalela. The network helps show where D. Dalela may publish in the future.

Co-authorship network of co-authors of D. Dalela

This figure shows the co-authorship network connecting the top 25 collaborators of D. Dalela. A scholar is included among the top collaborators of D. Dalela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Dalela. D. Dalela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalela, D., Stefania Pittaluga, Jagan Muppidi, et al.. (2023). IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL). Clinical Lymphoma Myeloma & Leukemia. 23. S451–S451. 1 indexed citations
2.
Hofstatter, Erin, Zuyun Liu, Tess A. O’Meara, et al.. (2022). Evidence of accelerated epigenetic aging of breast tissues in patients with breast cancer is driven by CpGs associated with polycomb-related genes. Clinical Epigenetics. 14(1). 30–30. 10 indexed citations
3.
Dalela, D., et al.. (2021). Impact of Covid-19 on Cancer Patients: A Single Center Experience and Comparison to National Data. The Journal of the American Medical Association (JAMA) Network (American Medical Association). 6(4). 1 indexed citations
4.
Patel, Shyam A., D. Dalela, Amy C. Fan, Maxwell R. Lloyd, & Tian Yi Zhang. (2021). Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy. Leukemia & lymphoma. 63(1). 10–18. 7 indexed citations
5.
Dalela, D., et al.. (2019). Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis. British Journal of Biomedical Science. 77(2). 69–75. 15 indexed citations
6.
Hofstatter, Erin, Steve Horvath, D. Dalela, et al.. (2018). Increased epigenetic age in normal breast tissue from luminal breast cancer patients. Clinical Epigenetics. 10(1). 112–112. 37 indexed citations
7.
8.
Dalela, D., et al.. (2016). W-V flap: a new technique for reconstruction of female distal urethral stricture using vestibular mucosa. BMJ Case Reports. 2016. bcr2016215309–bcr2016215309. 3 indexed citations
9.
Dalela, Divakar, et al.. (2016). Meatal Occlusive Disease in Adult Males: Are There Any Clinical Variations?. Urologia Internationalis. 97(2). 212–217. 1 indexed citations
10.
Srivastava, Anupam, et al.. (2014). Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma. Immunobiology. 219(6). 469–474. 30 indexed citations
11.
Singh, Pankaj Kumar, Anupam Srivastava, Srikanta Kumar Rath, et al.. (2014). Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma. Immunobiology. 220(1). 103–108. 29 indexed citations
12.
Singh, Deepak Kumar, et al.. (2010). Ascaris lumbricoides. Journal of Postgraduate Medicine. 56(3). 222–223. 6 indexed citations
13.
Goel, Apul, et al.. (2009). A cross-sectional pilot study to determine the prevalence of testosterone deficiency syndrome in working population of Indian men. Indian Journal of Urology. 25(2). 190–190. 4 indexed citations
14.
Goel, Apul, et al.. (2008). Harvesting Buccal Mucosa Graft Under Local Infiltration Analgesia—Mitigating Need for General Anesthesia. Urology. 72(3). 675–676. 9 indexed citations
15.
Dalela, D., Rajeev Sinha, Satyanarayan Sankhwar, & Vishwajeet Singh. (2007). VID-06.04: Ventral bulbar augmentation [VBA]: a technique to enhance support of buccal mucosal graft placed ventrally for proximal bulbar urethral strictures. Urology. 70(3). 186–186. 1 indexed citations
16.
Dalela, D.. (2005). Issues in etiology and diagnosis making of chyluria. Indian Journal of Urology. 21(1). 18–18. 20 indexed citations
17.
Singh, Krishna M., Apul Goel, Satya Narain Shankhwar, & D. Dalela. (2004). Confirmation of the correct placement of lower end of DJ stent during open surgery: Point of technique. International Urology and Nephrology. 36(3). 335–336. 3 indexed citations
18.
Dalela, D., et al.. (2004). Silver Nitrate Sclerotherapy for ‘Clinically Significant’ Chyluria: A Prospective Evaluation of Duration of Therapy. Urologia Internationalis. 72(4). 335–340. 25 indexed citations
19.
Dalela, D., et al.. (1992). Routine Radio‐imaging in Filarial Chyluria–Is it Necessary in Developing Countries?. British Journal of Urology. 69(3). 291–293. 15 indexed citations
20.
Dalela, D., Rajesh Ahlawat, & Vinod Mishra. (1992). Pre‐vesical Ureteric Calculi: Modified Prone Position for Extracorporeal Shock Wave Lithotripsy using the Siemens Lithostar. British Journal of Urology. 70(4). 456–457. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Gabilondo Breakdown of academic impact, for papers by Kyu-Rae Kim Breakdown of academic impact, for papers by J Dvořáček Breakdown of academic impact, for papers by Calogero Virgone Breakdown of academic impact, for papers by Mitsuhiro Tambo Breakdown of academic impact, for papers by B Court Breakdown of academic impact, for papers by D. Rosell Breakdown of academic impact, for papers by E Kairi-Vassilatou Breakdown of academic impact, for papers by Giuseppe Di Fino Breakdown of academic impact, for papers by G. Hofmockel
Rankless by CCL
2026